LNKD up +1.91% percent right now. $LNKD High is at 229.07

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
LNKD up +1.91% percent right now. $LNKD High is at 229.07 and the Low 221.66 with current volume of 677,472.

Recent News posted below.

LNKD Linkedin Recent Headline News

Third Quarter Results, Dividend Declarations, and New Services - Research Reports on LinkedIn, FireEye, CrownCastle, Cognizant and Level 3
PR Newswire - Mon Nov 10, 7:55AM CST
Today, Analysts Review released its research reports regarding LinkedIn Corporation (NYSE: LNKD), FireEye, Inc. (NASDAQ: FEYE), Crown Castle International Corp. (NYSE: CCI), Cognizant Technology Solutions Corporation (NASDAQ: CTSH) and Level 3 Communications, Inc. (NYSE: LVLT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7829-100free.
CCI: 79.61 (-0.19), LVLT: 46.12 (+0.27), FEYE: 31.92 (+1.30), LNKD: 227.13 (+4.09), CTSH: 53.92 (+0.30)

LinkedIn Has Yet Another Untapped Growth Market -- and It's Huge
Evan Niu, CFA, The Motley Fool - Motley Fool - Fri Nov 07, 12:05PM CST
Thanks to its professional positioning with the broader social media sector, LinkedIn has a wealth of opportunities that aren't afforded its consumer-centric peers. While Facebook and Twitter rely on core advertising businesses for the bulk of...
LNKD: 227.13 (+4.09), FB: 74.82 (-0.78), TWTR: 40.12 (-0.19), MSFT: 49.04 (+0.36), CRM: 63.77 (-0.20)

LinkedIn to Issue $1.15B Convertible Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:10PM CST
LinkedIn (LNKD) is set to issue $1.15 billion convertible senior notes scheduled to mature in 2019.
LNKD: 227.13 (+4.09), FB: 74.82 (-0.78), TWTR: 40.12 (-0.19), AAPL: 108.94 (-0.07)

Business Highlights
By The Associated Press - AP - Thu Nov 06, 4:56PM CST
___
MON: 115.69 (+1.25), LNKD: 227.13 (+4.09)


Bringing Mom & Dad to work bridges generation gap
By MICHAEL LIEDTKE - AP - Thu Nov 06, 2:38PM CST
MOUNTAIN VIEW, Calif. (AP) — Seta Whitford-Stark was dumbfounded last year when she found out her daughter Amy quit her job at an employee-recruiting agency to work for LinkedIn, an Internet company that Seta had never heard of. Amy tried to explain what the online professional networking service did, but Seta couldn't quite grasp the concept or why the 29-year-old would want to work there.
LNKD: 227.13 (+4.09)

Tableau, LinkedIn Lead Top 5 Tech Stocks On The Move
at Investor's Business Daily - Thu Nov 06, 2:17PM CST
Today's IBD Stocks On The Move list includes five highly rated tech companies showing strong percentage increases after recently reporting excellent earnings results. Sierra Wireless (SWIR), a maker of wireless and standard network gateways and...
SWIR: 34.68 (+0.78), LNKD: 227.13 (+4.09), FB: 74.82 (-0.78), IT: 84.32 (+0.78), TWTR: 40.12 (-0.19), DATA: 83.64 (-1.28), CDW: 32.89 (+0.30)

Stocks Cling To Modest Gains; Advance Auto Rebounds
at Investor's Business Daily - Thu Nov 06, 2:04PM CST
Stocks continued to hold slim gains Thursday afternoon. The Dow Jones industrial average led with a 0.3% gain, while the S&P 500 was up 0.2%. But the Nasdaq lagged with a 0.1% gain amid weakness in solar and chips. Volume was tracking lower across...
MNST: 106.62 (-1.77), ANET: 79.46 (+1.63), AAP: 143.79 (+1.94), SLXP: 93.64 (+2.17), DIS: 89.35 (-0.65), CDW: 32.89 (+0.30), NVDA: 19.94 (+0.15), FSLR: 51.95 (+1.66), LNKD: 227.13 (+4.09), LGF: 34.07 (+0.61), LOCO: 36.87 (+0.27), KING: 13.72 (unch)

LinkedIn (LNKD) Stock Higher Today After Announcing Sale of Senior Notes
at The Street - Thu Nov 06, 9:59AM CST
Shares on LinkedIn (LNKD) are up after the company announced the pricing of $1.15 billion aggregate principal amount for convertible senior notes due 2019.
LNKD: 227.13 (+4.09)

LinkedIn Corporation Announces Pricing of $1.15 Billion Convertible Notes Offering
GlobeNewswire - Thu Nov 06, 7:02AM CST
LinkedIn Corporation ("LinkedIn" (NYSE:LNKD) today announced the pricing of $1.15 billion aggregate principal amount of convertible senior notes due 2019 (the "notes" in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Act" . LinkedIn also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $172.5 million aggregate principal amount of the notes.
LNKD: 227.13 (+4.09)

Why LinkedIn Wants More Cash
Evan Niu, CFA, The Motley Fool - Motley Fool - Wed Nov 05, 1:30PM CST
Professional networker LinkedIn has just announced that it's raising cash through a convertible note offering. Specifically, the company is looking to raise $1.15 billion in funds to add to its coffers. On the last conference call, management...
LNKD: 227.13 (+4.09)

LinkedIn Corporation Announces $1.15 Billion Convertible Notes Offering
GlobeNewswire - Tue Nov 04, 3:01PM CST
LinkedIn Corporation (NYSE:LNKD) today announced its intention to offer, subject to market conditions and other factors, $1.15 billion aggregate principal amount of convertible senior notes due in 2019 (the "notes" in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Act" . LinkedIn also expects to grant the initial purchasers of the notes a 13-day option to purchase up to an additional $172.5 million aggregate principal amount of notes.
LNKD: 227.21 (+4.17)

Stocks Turn Mixed; Epam Bounces Back
at Investor's Business Daily - Tue Nov 04, 2:13PM CST
Stocks continued to improve late Tuesday, turning mixed. The Dow Jones industrial average bounced back from a 0.5% loss and was up a fraction. The broader Nasdaq and the S&P 500 were off 0.4% each. They had been off 0.9% and 0.8%, respectively. NYSE...
FEYE: 31.92 (+1.30), AWAY: 29.56 (+0.35), FRGI: 56.08 (+0.49), SAVE: 78.35 (+1.04), LNKD: 227.21 (+4.17), SCTY: 51.71 (+0.74), STE: 63.41 (+0.99), PZZA: 50.41 (+0.33), JAZZ: 171.55 (+0.75), FL: 54.52 (+0.02), EPAM: 46.48 (-0.47)

Insider Trading Alert - LNKD, IMPV And RE Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LNKD, IMPV and RE
RE: 171.48 (-0.86), LNKD: 227.21 (+4.17), IMPV: 42.92 (+0.39)

Wix.com Adds Two New Members to Board of Directors
GlobeNewswire - Mon Nov 03, 5:30PM CST
Wix.com Ltd. (Nasdaq:WIX), a leading global web development platform, today announced that Erika Rottenberg and Norbert Becker have joined the Wix Board of Directors. Ms. Rottenberg joined effective October 20, 2014 and Mr. Becker joined effective October 27, 2014. Both bring diverse and extensive experience to the Wix Board.
WIX: 17.35 (-0.09), LNKD: 227.21 (+4.17)

Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 227.21 (+4.17), ALXN: 194.29 (+0.48), ILMN: 188.66 (+2.31), REGN: 383.47 (+5.63), CRM: 63.77 (-0.20), CELG: 107.69 (+1.24)

HubSpot Small-Biz Focus May Counter Tech Giants
at Investor's Business Daily - Mon Nov 03, 3:42PM CST
HubSpot (HUBS) faces competition from tech giants, but its focus on small and midsize businesses sets it apart, says Morgan Stanley, which initiated coverage on the marketing automation software company with an equal weight rating. HubSpot stock has...
NOW: 68.70 (+0.91), LNKD: 227.21 (+4.17), FB: 74.82 (-0.78), WDAY: 94.72 (+0.16), GOOGL: 557.17 (+5.35), TWTR: 40.13 (-0.18), ADBE: 71.80 (+0.20), ORCL: 40.42 (+0.48), CRM: 63.77 (-0.20), HUBS: 36.72 (+0.02)

Stocks Finish Mixed As Oil Tumbles, Airlines Rise
at Investor's Business Daily - Mon Nov 03, 3:40PM CST
Stocks finished mixed Monday, deflating after a mild rally. Volume was lighter than Friday's hectic pace on both exchanges. The Nasdaq ended with a 0.2% gain; the Dow Jones industrial average dipped 0.1% and the S&P 500 was fractionally lower. The...
AMBA: 49.09 (+1.95), GPRO: 76.21 (-2.85), HA: 18.47 (+0.10), XOM: 96.24 (-0.35), ATHM: 43.79 (+0.16), UAL: 54.79 (+0.61), RYAAY: 61.21 (+0.58), SAVE: 78.35 (+1.04), Q: 57.42 (+0.21), LNKD: 227.21 (+4.17), CVX: 117.36 (-1.44)

5 Rocket Stocks to Buy for Earnings Season Gains: Bank of America, Salesforce.com and More
at The Street - Mon Nov 03, 12:20PM CST
Publicly traded companies have been quietly stomping analyst expectations across the board.
LNKD: 227.21 (+4.17), AVB: 157.99 (+0.69), BAC: 17.35 (-0.01), DLPH: 69.86 (+0.27), CRM: 63.77 (-0.20)

Technology Stock Roundup: FB/TWTR Crash in Earnings Aftermath - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Mon Nov 03, 9:31AM CST
A large number of technology companies reported last week including Facebook (FB), Twitter (TWTR), LinkedIn (LNKD) and Expedia (EXPE) but there were also updates on Apple (AAPL) Pay, Microsoft (MSFT) cloud and more.
YHOO: 49.29 (+0.74), LNKD: 227.21 (+4.17), FB: 74.82 (-0.78), EXPE: 86.00 (+0.89), TWTR: 40.13 (-0.18), MSFT: 49.04 (+0.36), AAPL: 108.95 (-0.06)

Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 116.19 (+3.33), LNKD: 227.21 (+4.17), HAL: 53.29 (-0.57), AGIO: 77.22 (+5.16), IMPV: 42.92 (+0.39)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading